Disease detectives
October 2009
Learn how Caris Diagnostics are using molecular profiling in the quest for personalized medicine.
Caris Diagnostics, based in Arizona USA, are positioning themselves for growth by not only expanding their portfolio of anatomic pathology and molecular profiling services, but also by expanding into blood-based molecular diagnostics.
In an interview with Thomson Reuters, Brian Wright, Vice President of Strategic Marketing, discusses the explosion of molecular diagnostics, and how it will ultimately enable physicians to more effectively detect and treat diseases earlier.
Hear our Intelligent Information for Life interview with Brian Wright
Was this article useful?
Register now to receive KnowledgeLink direct to your mailbox every two months.